AAAAAA

   
Results: 1-20 |
Results: 20
Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine
Authors: Kelly, DL Nelson, MW Love, RC Yu, Y Conley, RR
Citation: Dl. Kelly et al., Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine, PSYCH SERV, 52(5), 2001, pp. 676-678
Conclusions about risperidone - Reply
Authors: Kelly, DL Nelson, MW Love, RC Yu, Y Conley, RR
Citation: Dl. Kelly et al., Conclusions about risperidone - Reply, PSYCH SERV, 52(11), 2001, pp. 1535-1535
Evaluating clinical trial data: Outcome measures
Authors: Conley, RR
Citation: Rr. Conley, Evaluating clinical trial data: Outcome measures, J CLIN PSY, 62, 2001, pp. 23-28
A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research
Authors: Avila, MT Conley, RR Carpenter, WT
Citation: Mt. Avila et al., A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research, BIOL PSYCHI, 50(7), 2001, pp. 479-486
Biperiden for excessive sweating from clozapine
Authors: Richardson, C Kelly, DL Conley, RR
Citation: C. Richardson et al., Biperiden for excessive sweating from clozapine, AM J PSYCHI, 158(8), 2001, pp. 1329-1330
A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder
Authors: Conley, RR Mahmoud, R
Citation: Rr. Conley et R. Mahmoud, A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder, AM J PSYCHI, 158(5), 2001, pp. 765-774
A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder (vol 158, pg 765, 2001)
Authors: Conley, RR Mahmoud, R
Citation: Rr. Conley et R. Mahmoud, A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder (vol 158, pg 765, 2001), AM J PSYCHI, 158(10), 2001, pp. 1759-1759
Risperidone side effects
Authors: Conley, RR
Citation: Rr. Conley, Risperidone side effects, J CLIN PSY, 61, 2000, pp. 20-23
Adverse events related to olanzapine
Authors: Conley, RR Meltzer, HY
Citation: Rr. Conley et Hy. Meltzer, Adverse events related to olanzapine, J CLIN PSY, 61, 2000, pp. 26-29
Decisional capacity for informed consent in schizophrenia research
Authors: Carpenter, WT Gold, JM Lahti, AC Queern, CA Conley, RR Bartko, JJ Kovnick, J Appelbaum, PS
Citation: Wt. Carpenter et al., Decisional capacity for informed consent in schizophrenia research, ARCH G PSYC, 57(6), 2000, pp. 533-538
Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia
Authors: Gao, XM Sakai, K Roberts, RC Conley, RR Dean, B Tamminga, CA
Citation: Xm. Gao et al., Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia, AM J PSYCHI, 157(7), 2000, pp. 1141-1149
Differential olanzapine plasma concentrations by sex in a fixed-dose study
Authors: Kelly, DL Conley, RR Tamminga, CA
Citation: Dl. Kelly et al., Differential olanzapine plasma concentrations by sex in a fixed-dose study, SCHIZOPHR R, 40(2), 1999, pp. 101-104
Sense and nonsense: an essay on schizophrenia research ethics
Authors: Carpenter, WT Conley, RR
Citation: Wt. Carpenter et Rr. Conley, Sense and nonsense: an essay on schizophrenia research ethics, SCHIZOPHR R, 35(3), 1999, pp. 219-225
A dose-outcome analysis of risperidone
Authors: Love, RC Conley, RR Kelly, DL Bartko, JJ
Citation: Rc. Love et al., A dose-outcome analysis of risperidone, J CLIN PSY, 60(11), 1999, pp. 771-775
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
Authors: Conley, RR Tamminga, CA Kelly, DL Richardson, CM
Citation: Rr. Conley et al., Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response, BIOL PSYCHI, 46(1), 1999, pp. 73-77
Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine
Authors: Conley, RR Love, RC Kelly, DL Bartko, JJ
Citation: Rr. Conley et al., Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine, AM J PSYCHI, 156(6), 1999, pp. 863-868
Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta(1) protein in the prefrontal cortex of teenage suicide subjects
Authors: Pandey, GN Dwivedi, Y Pandey, SC Teas, SS Conley, RR Roberts, RC Tamminga, CA
Citation: Gn. Pandey et al., Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta(1) protein in the prefrontal cortex of teenage suicide subjects, AM J PSYCHI, 156(12), 1999, pp. 1895-1901
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: Comparison with risperidone
Authors: Moore, DB Kelly, DL Sherr, JD Love, RC Conley, RR
Citation: Db. Moore et al., Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: Comparison with risperidone, AM J HEAL S, 55, 1998, pp. S17-S19
Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months
Authors: Kelly, DL Conley, RR Love, RC Horn, DS Ushchak, CM
Citation: Dl. Kelly et al., Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months, J CH AD PSY, 8(3), 1998, pp. 151-159
Schizophrenia
Authors: Carpenter, WT Conley, RR Buchanan, RW
Citation: Wt. Carpenter et al., Schizophrenia, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, 1998, pp. 27-51
Risultati: 1-20 |